Rockefeller Capital Management
IBIO icon

Rockefeller Capital Management’s iBio IBIO Stock Holding History

Rockefeller Capital Management’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Buy
+1
New +$2 ﹤0.01% 4722
2022
Q1 		– Sell
-2
Closed – – 3961
2021
Q4 		$0 Sell
2
-1
-33% -$381 ﹤0.01% 3869
2021
Q3 		$1K Hold
3
– – ﹤0.01% 3578
2021
Q2 		$2K Buy
+3
New +$2.19K ﹤0.01% 3249

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Rockefeller Capital Management's IBIO Position: Q2 2026 in Review

Rockefeller Capital Management opened a new position in iBio (IBIO) in Q2 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #4722 among its holdings. This is a return to the name: Rockefeller Capital Management previously reported a position in IBIO as recently as Q4 2021.

Rockefeller Capital Management first reported a position in IBIO in Q2 2021 and has held it in 4 quarters since. The position peaked at $2K in Q2 2021. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • Rockefeller Capital Management held 1 share of iBio worth $2 as of Q2 2026.
  • iBio was a new Rockefeller Capital Management position in Q2 2026.
  • iBio made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4722 holding.
  • Rockefeller Capital Management first reported a position in iBio in Q2 2021 and has held it in 4 quarters since.
  • Rockefeller Capital Management's iBio position peaked at $2K in Q2 2021.
  • 55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.